Why it matters
OpenAI introduces GPT-Rosalind, a reasoning model for drug discovery, genomics, protein analysis, and life sciences research workflows.
My takeaway: Shows how frontier models are being specialized for high-stakes research workflows. Domain gains in life sciences also increase the need for rigorous evaluation, misuse boundaries, and human review.